On Feb 1, 2022 Centogene closed a Post-IPO Equity round and raised €15,000,000 from Careventures, DPE Deutsche Private Equity, TVM Capital Life Science, featuring lead investors Careventures, DPE Deutsche Private Equity, TVM Capital Life Science.

About the company: Centogene is located at Germany, Europe.
“CENTOGENE is a world leader in the field of genetic diagnostics for rare diseases dedicated to improve patients’ lives every day. Order your genetic test!”

Company website: http://www.centogene.com